XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Adoption of ASU No. 2016 -13 (Note 2)
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock Issued
Common Stock Issued
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Retained Earnings
Retained Earnings
Adoption of ASU No. 2016 -13 (Note 2)
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Balance at beginning of period (in shares) at Dec. 31, 2022       133,295,000 133,295,000              
Balance at beginning of period at Dec. 31, 2022 $ 622,404 $ (118) $ 622,286 $ 13 $ 13 $ 590,232 $ 590,232 $ 32,388 $ (118) $ 32,270 $ (229) $ (229)
Beginning balance, treasury stock (in shares) at Dec. 31, 2022                     (26,000) (26,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Grants of restricted stock (in shares)       403,000                
Cancellation of vesting shares (in shares)       (221,000)                
Vesting shares 1,287         1,287            
Stock-based compensation 1,813         1,813            
Purchase of treasury stock (in shares)                     (1,814,000)  
Purchase of treasury stock (12,345)                   $ (12,345)  
Common stock dividend declared (44,072)             (44,072)        
Common stock issued in warrant exchange (in shares)       2,576,000                
Common stock issued in warrant exchange 17,646     $ 1   17,645            
Common stock issued for exercise of warrants (in shares)       1,000                
Common stock issued for exercise of warrants 5         5            
Net income 63,560             63,560        
Balance at ending of period (in shares) at Sep. 30, 2023       136,054,000                
Balance at ending of period at Sep. 30, 2023 650,180     $ 14   610,982   51,758     $ (12,574)  
Ending balance, treasury stock (in shares) at Sep. 30, 2023                     (1,840,000)  
Balance at beginning of period (in shares) at Jun. 30, 2023       135,949,000                
Balance at beginning of period at Jun. 30, 2023 652,325     $ 14   609,909   48,610     $ (6,208)  
Beginning balance, treasury stock (in shares) at Jun. 30, 2023                     (972,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock-based compensation 379         379            
Purchase of treasury stock (in shares)                     (868,000)  
Purchase of treasury stock (6,366)                   $ (6,366)  
Common stock dividend declared (14,809)             (14,809)        
Common stock issued in warrant exchange (in shares)       104,000                
Common stock issued in warrant exchange 689         689            
Common stock issued for exercise of warrants (in shares)       1,000                
Common stock issued for exercise of warrants 5         5            
Net income 17,957             17,957        
Balance at ending of period (in shares) at Sep. 30, 2023       136,054,000                
Balance at ending of period at Sep. 30, 2023 $ 650,180     $ 14   610,982   51,758     $ (12,574)  
Ending balance, treasury stock (in shares) at Sep. 30, 2023                     (1,840,000)  
Balance at beginning of period (in shares) at Dec. 31, 2023 136,040,777     136,041,000                
Balance at beginning of period at Dec. 31, 2023 $ 671,645     $ 14   653,174   54,782     $ (36,325)  
Beginning balance, treasury stock (in shares) at Dec. 31, 2023 (5,677,627)                   (5,678,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Grants of restricted stock (in shares)       383,000                
Stock-based compensation $ 1,683         1,683            
Purchase of treasury stock (in shares)                     (2,000)  
Purchase of treasury stock (17)                   $ (17)  
Common stock dividend declared (43,112)             (43,112)        
Net income $ 30,381             30,381        
Balance at ending of period (in shares) at Sep. 30, 2024 136,424,207     136,424,000                
Balance at ending of period at Sep. 30, 2024 $ 660,580     $ 14   654,857   42,051     $ (36,342)  
Ending balance, treasury stock (in shares) at Sep. 30, 2024 (5,680,255)                   (5,680,000)  
Balance at beginning of period (in shares) at Jun. 30, 2024       136,424,000                
Balance at beginning of period at Jun. 30, 2024 $ 665,321     $ 14   654,269   47,380     $ (36,342)  
Beginning balance, treasury stock (in shares) at Jun. 30, 2024                     (5,680,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock-based compensation 588         588            
Common stock dividend declared (14,383)             (14,383)        
Net income $ 9,054             9,054        
Balance at ending of period (in shares) at Sep. 30, 2024 136,424,207     136,424,000                
Balance at ending of period at Sep. 30, 2024 $ 660,580     $ 14   $ 654,857   $ 42,051     $ (36,342)  
Ending balance, treasury stock (in shares) at Sep. 30, 2024 (5,680,255)                   (5,680,000)